{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:11:04Z","timestamp":1779300664647,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bulcan.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:14:43Z","timestamp":1775823283000},"page":"719-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of neoadjuvant chemotherapy plus concurrent chemoradiotherapy in locally advanced nasopharyngeal cancer: A real-world study"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8119-1061","authenticated-orcid":false,"given":"Amine","family":"Lachgar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Hassnaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith Tatiana","family":"Ngbwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"El Gueddari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moulay Ali","family":"Youssoufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Adnane Tazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Nouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"El Kacemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayeb","family":"Kebdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Hassouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.02.007_bib0170","doi-asserted-by":"crossref","first-page":"e49968","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling","volume":"9","author":"Zhang","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0175","series-title":"Registre des Cancers de la R\u00e9gion du Grand Casablanca 2018\u20132021 [Internet]","year":"2024"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0180","series-title":"Registre des Cancers de la R\u00e9gion de Rabat 2009\u20132012 [Internet]","year":"2015"},{"issue":"3","key":"10.1016\/j.bulcan.2026.02.007_bib0185","doi-asserted-by":"crossref","first-page":"e251895","DOI":"10.1001\/jamanetworkopen.2025.1895","article-title":"Patient characteristics and treatment outcomes of nasopharyngeal carcinoma in nonendemic regions","volume":"8","author":"Alsavaf","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"24","key":"10.1016\/j.bulcan.2026.02.007_bib0190","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1200\/JCO.22.02764","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"41","author":"Al-Sarraf","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2026.02.007_bib0195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.bulcan.2026.02.007_bib0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2026.02.007_bib0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial","volume":"119","author":"Yang","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.007_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.32099","article-title":"Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial","volume":"145","author":"Li","year":"2019","journal-title":"Int J Cancer"},{"issue":"22","key":"10.1016\/j.bulcan.2026.02.007_bib0220","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.22.00327","article-title":"Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: a multicenter, randomized phase III trial","volume":"40","author":"Zhang","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2026.02.007_bib0225","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1470-2045(23)00163-8","article-title":"Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis","volume":"24","author":"Petit","year":"2023","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2026.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/sj.bjc.6690627","article-title":"Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study","volume":"80","author":"Hong","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0235","first-page":"1829","article-title":"Is the gemcitabin-cisplatin combination the optimal induction chemotherapy for non-Asian patients with nasopharyngeal carcinoma (NPC)? Insights from a cohort in northeastern Morocco","volume":"19","author":"Oumaima Talbi","year":"2025","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0240","series-title":"American Joint Committee on Cancer AJCC cancer staging manual","author":"Amin","year":"2017"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.007_bib0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.007_bib0250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2026.02.007_bib0255","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","article-title":"International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma","volume":"105","author":"Lee","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0260","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) v4.0 [Internet]","year":"2009"},{"issue":"4","key":"10.1016\/j.bulcan.2026.02.007_bib0265","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","article-title":"Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2026.02.007_bib0270","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II\u2013IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0275","doi-asserted-by":"crossref","first-page":"703995","DOI":"10.3389\/fonc.2021.703995","article-title":"Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: a systematic review of the literature","volume":"11","author":"Chiang","year":"2021","journal-title":"Front Oncol"},{"issue":"40","key":"10.1016\/j.bulcan.2026.02.007_bib0280","doi-asserted-by":"crossref","first-page":"66170","DOI":"10.18632\/oncotarget.10818","article-title":"Old age at diagnosis increases risk of tumor progression in nasopharyngeal cancer","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bulcan.2026.02.007_bib0285","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/hed.27689","article-title":"Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III\u2013IVa nasopharyngeal carcinoma: a real-world study based on medical comorbidities","volume":"46","author":"Jin","year":"2024","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.007_bib0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13014-022-02095-2","article-title":"Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study","volume":"17","author":"Wu","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0295","doi-asserted-by":"crossref","first-page":"105506","DOI":"10.1016\/j.oraloncology.2021.105506","article-title":"Survival impact of increasing time to IMRT initiation following induction chemotherapy in nasopharyngeal carcinoma: a propensity score-matched analysis","volume":"122","author":"Zhou","year":"2021","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.02.007_bib0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12885-018-4210-3","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma","volume":"18","author":"Setakornnukul","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.oraloncology.2018.04.020","article-title":"Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy","volume":"81","author":"Mott","year":"2018","journal-title":"Oral Oncol"},{"issue":"49","key":"10.1016\/j.bulcan.2026.02.007_bib0310","doi-asserted-by":"crossref","first-page":"e13483","DOI":"10.1097\/MD.0000000000013483","article-title":"Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bulcan.2026.02.007_bib0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2016.12.039","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase III multicentre randomised controlled trial","volume":"75","author":"Cao","year":"2017","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.bulcan.2026.02.007_bib0320","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2026.02.007_bib0325","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bulcan.2026.02.007_bib0330","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejrad.2012.06.031","article-title":"Accuracy of whole-body FDG-PET and FDG-PET\/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis","volume":"82","author":"Chang","year":"2013","journal-title":"Eur J Radiol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512600175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512600175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:57:55Z","timestamp":1779299875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745512600175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S000745512600175X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.02.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of neoadjuvant chemotherapy plus concurrent chemoradiotherapy in locally advanced nasopharyngeal cancer: A real-world study","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}